Literature DB >> 29061245

Neurosarcoidosis.

Patompong Ungprasert1, Eric L Matteson2.   

Abstract

Neurosarcoidosis occurs in 3% to 10% of patients with sarcoidosis. Cranial neuropathy and meningeal involvement are the most common manifestations, but any part of the nervous system can be affected. Definite diagnosis requires the presence of noncaseating granuloma in the nervous system, although histopathologic confirmation is often not obtainable. Moderate to high dose of glucocorticoids is the main therapy for neurosarcoidosis. Relapse often occurs after the dose of glucocorticoids is tapered down, often necessitating the use of steroid-sparing immunosuppressive agents.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical manifestation; Imaging study; Neurosarcoidosis; Outcome; Sarcoidosis; Treatment

Mesh:

Year:  2017        PMID: 29061245     DOI: 10.1016/j.rdc.2017.06.008

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  11 in total

1.  Hydrocephalus associated to posterior fossa tumor-like sarcoidosis: A case report and literature review.

Authors:  Ghassen Gader; Chaden Fakhfakh; Alia Zehani; Sabeur Thamlaoui; Ihsèn Zammel; Mouna Rkhami; Mohamed Badri
Journal:  Caspian J Intern Med       Date:  2022

Review 2.  Neurosarcoidosis: Phenotypes, Approach to Diagnosis and Treatment.

Authors:  Jeanne Gosselin; Chantal Roy-Hewitson; Sean S M Bullis; John C DeWitt; Bruno P Soares; Sidarth Dasari; Alana Nevares
Journal:  Curr Rheumatol Rep       Date:  2022-10-12       Impact factor: 4.686

3.  Clinical Spectrum and Outcome of Neurosarcoidosis: A Retrospective Cohort Study from a Teaching Hospital in India.

Authors:  Arun Mathai Mani; A T Prabhakar; Pavithra Mannam; Rohit Ninan Benjamin; Atif Iqbal Ahmed Shaikh; Donna Mathew; Pankaj Singh; Aditya Nair; P T Alexander; Asish Vijayaraghavan; Ajith Sivadasan; Sunithi Mani; Vivek Mathew; Sanjith Aaron; Mathew Alexander
Journal:  Ann Indian Acad Neurol       Date:  2020-06-29       Impact factor: 1.383

Review 4.  Two cases of sarcoidosis presenting as longitudinally extensive transverse myelitis.

Authors:  Amanda Mary Scott; Janeth Yinh; Timothy McAlindon; Robert Kalish
Journal:  Clin Rheumatol       Date:  2018-05-17       Impact factor: 2.980

Review 5.  Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art.

Authors:  Francesca Polverino; Elisabetta Balestro; Paolo Spagnolo
Journal:  J Clin Med       Date:  2020-07-24       Impact factor: 4.241

6.  Application of the modified Zajicek criteria to diagnose probable spinal cord neurosarcoidosis.

Authors:  Ceris Ifan Owen; Farrah Jabeen; Anupam Bhattacharjee
Journal:  Clin Case Rep       Date:  2018-07-10

7.  Bone marrow involvement in sarcoidosis: an elusive extrapulmonary manifestation.

Authors:  J Isaac Peña-Garcia; Sana Shaikh; Bhishma Barakoti; Christos Papageorgiou; Alexandre Lacasse
Journal:  J Community Hosp Intern Med Perspect       Date:  2019-04-12

Review 8.  Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis.

Authors:  Patompong Ungprasert; Jay H Ryu; Eric L Matteson
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-08-02

9.  Relevance of Medullary Vein Sign in Neurosarcoidosis.

Authors:  Richard Liberio; Emily Kramer; Anza B Memon; Ryan Reinbeau; Parissa Feizi; Joe Joseph; Janet Wu; Shitiz Sriwastava
Journal:  Neurol Int       Date:  2022-08-14

10.  Association Between Treatment-Resistant Sarcoid Myopathy and Inclusion Body Myositis.

Authors:  Dario A Marotta; Hassan Kesserwani
Journal:  Cureus       Date:  2020-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.